experimental drugs

Doctors must be open with their patients about death

When faced with a terminal diagnosis, it may initially seem logical to provide patients with access to experimental treatments in a last ditch attempt at survival. However, while these treatments should be accessible to patients, they should not be considered ‘go-to’ treatment options by the desperate. In Canada, we have the Special Access Programme (SAP), which makes accessible drugs that are not yet approved in Canada, including those still in experimental phases. Many Western individuals question whether the terminally ill should have access to these treatments, feeling the program does more harm than good. Some argue that treating individuals with…

Continue reading